HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

65.400

-0.600-0.91%

Volume:2.11M

Turnover:139.35M

Market Cap:434.06B

PE:48.92

High:67.000

Open:64.900

Low:64.550

Close:66.000

52wk High:95.200

52wk Low:52.500

Shares:6.64B

HK Float Shares:258.00M

Volume Ratio:1.54

T/O Rate:0.82%

Dividend:- -

Dividend Rate:- -

EPS(LYR):1.337

ROE:14.31%

ROA:8.42%

PB:6.25

PE(LYR):48.92

PS:12.11

Loading ...

Overview Company News Filings

Hengrui Pharma Subsidiary Receives Approval for Adebeli Monoclonal Antibody Clinical Trial

Biopharma Stocks Rally as Sector Gains Strategic "Emerging Pillar" Status

HENGRUI PHARMA Subsidiary Receives Clinical Trial Approval for Drug Candidate HRS-1780 Tablets

Jiangsu Hengrui Pharmaceuticals (600276) Announces Share Repurchase and Updated Issued Shares

Bulletin Express

HENGRUI PHARMA Repurchases 630,000 A Shares for 33.98 Million Yuan on March 3

Jiangsu Hengrui Pharmaceuticals (01276) Reports February 2026 Securities Movements

Bulletin Express

Jiangsu Hengrui Pharmaceuticals (1276) Announces New Board Election and Director Changes

Bulletin Express

HENGRUI PHARMA Announces Board of Directors Restructuring

Hengrui Pharma (600276) Announces A Share Repurchase

Bulletin Express

UBS Forecasts 10% Revenue Growth for Healthcare Sector This Year, Names 3SBIO as Top Pick

Hengrui Pharma Allocates 15.63 Million Yuan for Share Buyback on February 26

Jiangsu Hengrui (600276) Announces Share Repurchase Results

Bulletin Express

GTHT: Factor XI Drives New Era in Anticoagulant Therapy with Multi-Technological Approaches

China's Drug Regulator Puts Hengrui Pharmaceuticals' SHR-1918 Injection in Priority Review

MT Newswires Live

Hengrui Pharma's Novel Drug SHR-1918 Injection Receives Marketing Application Acceptance and Priority Review Status

Hengrui Pharma's Innovative Drug HRS-5346 for Elevated Lipoprotein(a) Levels Added to Breakthrough Therapy List

Small Nucleic Acids Reshape Weight Loss Paradigm with INHBE and ALK7 Targets Showing Initial Validation

Jiangsu Hengrui Medicine Gets Priority Review Approval for Colorectal Cancer Drug

MT Newswires Live

HENGRUI PHARMA's New Antibody Drug Application for Injectable SHR-A1811 Accepted and Granted Priority Review

Hengrui Pharma's HRS-4642 Injection Granted Breakthrough Therapy Designation

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/01276/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"01276","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"HENGRUI PHARMA","latestPrice":65.4,"timestamp":1774843500002,"preClose":66,"halted":0,"volume":2108988,"delay":0,"changeRate":-0.009090909090909005,"floatShares":258000000,"shares":6637000000,"eps":1.336897686149797,"marketStatus":"Noon Closed","change":-0.6,"latestTime":"03-30 12:05:00","open":64.9,"high":67,"low":64.55,"amount":139346861,"amplitude":0.037121,"askPrice":65.45,"askSize":5000,"bidPrice":65.35,"bidSize":10200,"shortable":3,"etf":0,"ttmEps":1.336897686149797,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1774846800000},"marketStatusCode":3,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":66,"openAndCloseTimeList":[[1774834200000,1774843200000],[1774846800000,1774857600000]],"volumeRatio":1.540474,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"Jiangsu Hengrui Pharmaceuticals Co.,Ltd.","latestPrice":55.85,"timestamp":1774841402000,"preClose":55.18,"halted":0,"volume":49022000,"delay":0,"premium":"+3.36"}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"01276\",,,,,undefined,":{"symbol":"01276","floatShares":258000000,"roa":"8.42%","roe":"14.31%","lyrEps":1.336898,"volumeRatio":1.540474,"shares":6637000000,"dividePrice":0,"high":67,"amplitude":0.037121,"preClose":66,"low":64.55,"week52Low":52.5,"pbRate":"6.25","psRate":"12.11","week52High":95.2,"institutionHeld":0,"latestPrice":65.4,"committee":0.342105,"eps":1.336897686149797,"divideRate":0,"volume":2108988,"delay":0,"ttmEps":1.336897686149797,"open":64.9,"prevYearClose":71.25,"prevWeekClose":66,"prevMonthClose":66.5,"prevQuarterClose":71.25,"fiveDayClose":61.8,"twentyDayClose":64,"sixtyDayClose":71.3},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/01276\",params:#limit:5,,,undefined,":[{"date":"2026-03-26","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774488600000,"name":null,"time":"","dateTimestamp":1774454400000,"actualEps":null},{"date":"2025-10-28","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761615000000,"name":null,"time":"","dateTimestamp":1761580800000,"actualEps":null},{"date":"2025-08-21","symbol":"01276","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1755739800000,"name":null,"time":"","dateTimestamp":1755705600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"01276\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"01276\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2222,"buy":0.6667,"hold":0.1111,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":9,"updateTime":1772208000000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/01276\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"01276","date":"2026-03-27","current":48.94115,"percent":0.014218,"low":44.415436,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"high":65.582363,"avg":55.568695,"sd":4.750737,"marketCap":414588875872.42},"quantilePoints":[{"date":"2025-05-23","current":52.570963,"twenty":52.783176,"median":53.101495,"eighty":53.419815,"marketCap":390693388207.53},{"date":"2025-05-30","current":53.015805,"twenty":51.822085,"median":52.540895,"eighty":52.926837,"marketCap":395731540422.24},{"date":"2025-06-06","current":52.120101,"twenty":52.130014,"median":52.555929,"eighty":53.075252,"marketCap":390038198012.59},{"date":"2025-06-13","current":52.209491,"twenty":52.177631,"median":52.691227,"eighty":53.357137,"marketCap":390861633032.23},{"date":"2025-06-20","current":50.172412,"twenty":51.591196,"median":52.469796,"eighty":53.075252,"marketCap":374874997562.85},{"date":"2025-06-27","current":50.314776,"twenty":50.363569,"median":52.169666,"eighty":53.013533,"marketCap":376991477472.78},{"date":"2025-07-04","current":51.666141,"twenty":50.343584,"median":52.120101,"eighty":53.004446,"marketCap":387134991658.26},{"date":"2025-07-11","current":55.507007,"twenty":50.44351,"median":52.13337,"eighty":53.090114,"marketCap":415495681161.23},{"date":"2025-07-18","current":57.272274,"twenty":50.582121,"median":52.209491,"eighty":54.057606,"marketCap":428373566715.29},{"date":"2025-07-25","current":54.897923,"twenty":50.594414,"median":52.555929,"eighty":55.711415,"marketCap":412107620053.2},{"date":"2025-08-01","current":59.731878,"twenty":50.855059,"median":52.994419,"eighty":55.972407,"marketCap":445624526286.47},{"date":"2025-08-08","current":59.478715,"twenty":51.107295,"median":53.05296,"eighty":56.541585,"marketCap":444845815775.64},{"date":"2025-08-15","current":61.917611,"twenty":51.356483,"median":53.519848,"eighty":59.478715,"marketCap":462392609292.46},{"date":"2025-08-22","current":58.782188,"twenty":51.569512,"median":54.477764,"eighty":60.15932,"marketCap":470428104569.66},{"date":"2025-08-29","current":59.85298,"twenty":51.666141,"median":55.691374,"eighty":59.937003,"marketCap":481284287403.35},{"date":"2025-09-05","current":65.582363,"twenty":51.677932,"median":55.770266,"eighty":60.732448,"marketCap":526832269752.24},{"date":"2025-09-12","current":62.481332,"twenty":51.8337,"median":55.972407,"eighty":61.285609,"marketCap":502824785657.99},{"date":"2025-09-19","current":63.179889,"twenty":52.120101,"median":56.254853,"eighty":61.852995,"marketCap":508085671393.42},{"date":"2025-09-26","current":63.528382,"twenty":52.146639,"median":56.965096,"eighty":62.270337,"marketCap":509562668601.01},{"date":"2025-10-03","current":64.989073,"twenty":52.165061,"median":57.272274,"eighty":62.504861,"marketCap":522523002865.02},{"date":"2025-10-10","current":61.782766,"twenty":52.193561,"median":59.039802,"eighty":62.657943,"marketCap":496019912951.91},{"date":"2025-10-17","current":58.903713,"twenty":52.323014,"median":59.170669,"eighty":62.619084,"marketCap":472537436949.31},{"date":"2025-10-24","current":59.187086,"twenty":52.484015,"median":59.039802,"eighty":62.52839,"marketCap":474983377696.11},{"date":"2025-10-31","current":57.072441,"twenty":52.552922,"median":59.021138,"eighty":62.417499,"marketCap":465758305542.93},{"date":"2025-11-07","current":54.713071,"twenty":52.619069,"median":58.881843,"eighty":62.304573,"marketCap":446224987036.64},{"date":"2025-11-14","current":55.883072,"twenty":52.812504,"median":58.231971,"eighty":62.27542,"marketCap":457058673340.29},{"date":"2025-11-21","current":52.805265,"twenty":52.880927,"median":57.030538,"eighty":62.209511,"marketCap":431684582485.14},{"date":"2025-11-28","current":55.237621,"twenty":52.99843,"median":56.630614,"eighty":62.069705,"marketCap":453209419829.34},{"date":"2025-12-05","current":54.841023,"twenty":53.00899,"median":56.437545,"eighty":61.965159,"marketCap":450729029423.46},{"date":"2025-12-12","current":56.212257,"twenty":53.045529,"median":56.385682,"eighty":61.891765,"marketCap":462853512587.19},{"date":"2025-12-19","current":54.083493,"twenty":53.045529,"median":56.227363,"eighty":61.831221,"marketCap":446374731108.34},{"date":"2025-12-24","current":54.414957,"twenty":53.090114,"median":56.103073,"eighty":61.798561,"marketCap":450509359276.9},{"date":"2026-01-02","current":53.078544,"twenty":53.065996,"median":55.972407,"eighty":61.785925,"marketCap":441174507319.22},{"date":"2026-01-09","current":56.743223,"twenty":53.0878,"median":56.0944,"eighty":61.695241,"marketCap":472808676524.34},{"date":"2026-01-16","current":55.187351,"twenty":53.304215,"median":56.103073,"eighty":61.405393,"marketCap":461338821289.95},{"date":"2026-01-23","current":52.546341,"twenty":53.0878,"median":56.076447,"eighty":61.296167,"marketCap":438839874056.97},{"date":"2026-01-30","current":51.677141,"twenty":52.994149,"median":55.908509,"eighty":61.278475,"marketCap":433553740508.2},{"date":"2026-02-06","current":50.918226,"twenty":52.680723,"median":55.839154,"eighty":61.101743,"marketCap":428270226283.58},{"date":"2026-02-13","current":51.771686,"twenty":52.512455,"median":55.711415,"eighty":60.890064,"marketCap":437949787160.49},{"date":"2026-02-20","current":51.752043,"twenty":52.351169,"median":55.691374,"eighty":60.824953,"marketCap":437153052005.04},{"date":"2026-02-27","current":50.215456,"twenty":52.151244,"median":55.507566,"eighty":60.720339,"marketCap":428825318404.97},{"date":"2026-03-06","current":49.335298,"twenty":51.80347,"median":55.280584,"eighty":60.654676,"marketCap":417912584744.19},{"date":"2026-03-13","current":48.90444,"twenty":51.75217,"median":55.201025,"eighty":60.572606,"marketCap":416170839186.33},{"date":"2026-03-20","current":48.948437,"twenty":51.671435,"median":55.086674,"eighty":60.515374,"marketCap":414967977646.95},{"date":"2026-03-27","current":47.483832,"twenty":51.400677,"median":54.94883,"eighty":60.443129,"marketCap":414588875872.42}],"updateTime":1774843206897},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"01276\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1172641395","title":"Hengrui Pharma Subsidiary Receives Approval for Adebeli Monoclonal Antibody Clinical Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1172641395","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172641395?lang=en_us&edition=fundamental","pubTime":"2026-03-06 17:20","pubTimestamp":1772788856,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276.SH) has announced that its subsidiary, Shanghai Shengdi Pharmaceutical Co., Ltd., recently obtained a drug clinical trial approval notice from the...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU2488822045.USD","LU1328615791.USD","LU1997244956.HKD","LU0359201885.HKD","LU1997245094.SGD","01276","LU2328871848.SGD","LU1064131003.USD","BK0012","LU0405327494.USD","BK0196","LU0405327148.USD","LU0359201612.USD","LU1255011170.USD","LU2543165471.USD","LU2097828805.USD","LU2097828474.EUR","BK0239","LU2580892862.HKD","LU1781817850.SGD","LU1580142542.USD","LU1820825898.SGD","LU2097828631.EUR","BK0028","600276","LU1146622755.USD","LU2580892789.USD","BK0183","LU1969619763.USD","LU0359202008.SGD","LU2097828557.USD","LU2148510915.USD","LU1023057109.AUD","LU1997245177.USD","LU1655091616.SGD","LU2097828714.EUR","BK0060","LU2289578879.USD","LU1064130708.USD","BK0188","LU2495084118.USD"],"gpt_icon":0},{"id":"1115207358","title":"Biopharma Stocks Rally as Sector Gains Strategic \"Emerging Pillar\" Status","url":"https://stock-news.laohu8.com/highlight/detail?id=1115207358","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115207358?lang=en_us&edition=fundamental","pubTime":"2026-03-06 10:14","pubTimestamp":1772763264,"startTime":"0","endTime":"0","summary":"Innovative drug stocks strengthened during the morning session. At the time of writing, HUTCHMED (00013) rose 9.02% to HK$22.96; 3SBIO (01530) increased 8.41% to HK$21.4; HENGRUI PHARMA (01276)...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["399441","VXUS","BK1587","06978","BK1583","BK1593","LU2097828805.USD","159992","LU2242644610.SGD","BK4585","LU2328871848.SGD","LU2097828557.USD","BK1574","LU2097828631.EUR","02162","161726","01276","LU0359201612.USD","BK1589","BK1588","LU0359202008.SGD","LU1969619763.USD","00013","LU2097828714.EUR","VT","BK4588","BK1161","01530","LABU","01801","BK1191","HK0000165453.HKD","LU0359201885.HKD","LU0455707207.USD","LU1023057109.AUD","LU2097828474.EUR","LU2543165471.USD","LU0502904849.HKD","LU2488822045.USD"],"gpt_icon":0},{"id":"1180723901","title":"HENGRUI PHARMA Subsidiary Receives Clinical Trial Approval for Drug Candidate HRS-1780 Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=1180723901","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180723901?lang=en_us&edition=fundamental","pubTime":"2026-03-04 17:08","pubTimestamp":1772615309,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) has announced that its subsidiary, Shandong Shengdi Pharmaceutical Co., Ltd., recently obtained a drug clinical trial approval notice for HRS-1780 tablets from the National...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0359202008.SGD","LU2580892862.HKD","BK0060","LU2543165471.USD","LU2580892789.USD","BK1191","LU0359201612.USD","LU1255011170.USD","LU2488822045.USD","BK0188","01276","LU0405327148.USD","LU1820825898.SGD","BK0183","BK0239","LU1781817850.SGD","LU2328871848.SGD","LU1023057109.AUD","LU2495084118.USD","BK0196","LU1064131003.USD","LU2097828805.USD","LU2097828714.EUR","LU1997245177.USD","LU1146622755.USD","LU2148510915.USD","LU1655091616.SGD","LU2097828557.USD","LU1997245094.SGD","LU2289578879.USD","BK0012","LU1969619763.USD","BK0028","LU1328615791.USD","LU2097828474.EUR","LU1580142542.USD","LU0359201885.HKD","LU1064130708.USD","600276","LU2097828631.EUR","LU0405327494.USD","LU1997244956.HKD"],"gpt_icon":0},{"id":"1144312966","title":"Jiangsu Hengrui Pharmaceuticals (600276) Announces Share Repurchase and Updated Issued Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=1144312966","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1144312966?lang=en_us&edition=fundamental","pubTime":"2026-03-03 17:22","pubTimestamp":1772529746,"startTime":"0","endTime":"0","summary":"On March 3, 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. disclosed a repurchase of 0.63 million A shares, representing 0.0099% of the total issued shares prior to the transaction. According to the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"gpt_icon":0},{"id":"1110689804","title":"HENGRUI PHARMA Repurchases 630,000 A Shares for 33.98 Million Yuan on March 3","url":"https://stock-news.laohu8.com/highlight/detail?id=1110689804","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110689804?lang=en_us&edition=fundamental","pubTime":"2026-03-03 17:13","pubTimestamp":1772529186,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) announced that on March 3, 2026, it repurchased 630,000 A shares at a total cost of RMB 33.9821 million.","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","LU2097828805.USD","LU2148510915.USD","LU2580892862.HKD","LU1580142542.USD","LU1328615791.USD","LU1969619763.USD","LU2328871848.SGD","BK0188","LU0405327494.USD","LU1781817850.SGD","BK0012","LU0359201612.USD","BK0196","LU0359202008.SGD","LU0359201885.HKD","159982","LU0405327148.USD","600276","LU1146622755.USD","LU2488822045.USD","LU1997244956.HKD","BK0183","LU1064131003.USD","LU2097828474.EUR","LU2097828631.EUR","LU1997245177.USD","01276","BK0028","LU2580892789.USD","LU1023057109.AUD","BK0239","LU1820825898.SGD","LU1655091616.SGD","LU2289578879.USD","LU1255011170.USD","LU2543165471.USD","LU1997245094.SGD","LU2495084118.USD","399300","LU2097828557.USD","LU2097828714.EUR","BK0060","LU1064130708.USD"],"gpt_icon":0},{"id":"1183273842","title":"Jiangsu Hengrui Pharmaceuticals (01276) Reports February 2026 Securities Movements","url":"https://stock-news.laohu8.com/highlight/detail?id=1183273842","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183273842?lang=en_us&edition=fundamental","pubTime":"2026-03-03 17:11","pubTimestamp":1772529084,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. announced that its total authorized share capital at the end of February 2026 remained at 6.64 billion shares. This figure comprises 258.20 million H shares...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"gpt_icon":0},{"id":"1142931366","title":"Jiangsu Hengrui Pharmaceuticals (1276) Announces New Board Election and Director Changes","url":"https://stock-news.laohu8.com/highlight/detail?id=1142931366","media":"Bulletin Express","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1142931366?lang=en_us&edition=fundamental","pubTime":"2026-03-02 23:01","pubTimestamp":1772463706,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (1276) disclosed proposals for the tenth session of its Board, including re-elections, an independent non-executive director’s retirement, and a new...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"gpt_icon":0},{"id":"1169983629","title":"HENGRUI PHARMA Announces Board of Directors Restructuring","url":"https://stock-news.laohu8.com/highlight/detail?id=1169983629","media":"Stock News","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169983629?lang=en_us&edition=fundamental","pubTime":"2026-03-02 22:52","pubTimestamp":1772463140,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA (01276) has issued an announcement regarding the upcoming expiration of its Ninth Board of Directors' term. In accordance with the company's Articles of Association and relevant...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0405327148.USD","01276","LU1781817850.SGD","BK0239","LU1580142542.USD","LU2097828474.EUR","BK0060","LU1820825898.SGD","LU2097828805.USD","LU0405327494.USD","BK0188","BK0196","LU1997245094.SGD","LU2580892862.HKD","LU2097828714.EUR","LU1328615791.USD","LU2289578879.USD","BK0012","LU2543165471.USD","LU1064131003.USD","LU1969619763.USD","LU1655091616.SGD","600276","LU0359202008.SGD","LU1023057109.AUD","LU2097828557.USD","BK0183","LU1146622755.USD","LU1997245177.USD","BK1191","LU0359201612.USD","LU2495084118.USD","LU1997244956.HKD","LU0359201885.HKD","LU2580892789.USD","LU2488822045.USD","LU1064130708.USD","LU1255011170.USD","LU2097828631.EUR","LU2148510915.USD","BK0028","LU2328871848.SGD"],"gpt_icon":0},{"id":"1162621372","title":"Hengrui Pharma (600276) Announces A Share Repurchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1162621372","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162621372?lang=en_us&edition=fundamental","pubTime":"2026-03-02 17:41","pubTimestamp":1772444488,"startTime":"0","endTime":"0","summary":"On 02 March 2026, Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276) repurchased 0.62 million of its A Shares for the A Share Employee Stock Ownership Schemes. This transaction represented about...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"gpt_icon":0},{"id":"1148570608","title":"UBS Forecasts 10% Revenue Growth for Healthcare Sector This Year, Names 3SBIO as Top Pick","url":"https://stock-news.laohu8.com/highlight/detail?id=1148570608","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148570608?lang=en_us&edition=fundamental","pubTime":"2026-03-02 14:07","pubTimestamp":1772431669,"startTime":"0","endTime":"0","summary":"UBS has released a research report projecting that the median revenue growth for rated healthcare companies will reach 16% in 2025 and 10% in 2026, based on the latest industry sales data and...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0067412154.USD","BK1515","IE00B031HY20.USD","IE00BZ08YR35.GBP","LU1328277881.USD","LU1226288253.USD","BK1191","BK1593","LU2039709279.SGD","LU0359201885.HKD","LU1226288170.HKD","LU1226287529.USD","01530","LU0315179316.USD","LU1813983027.USD","IE00BZ08YS42.EUR","HK0000165453.HKD","LU1152091168.USD","LU1226287792.SGD","LU1993786604.SGD","XBI","IE00BZ08YT58.USD","LU0359201612.USD","LU0501845795.SGD","LU1951186391.HKD","LU1023057109.AUD","03692","LU0072913022.USD","LU0140636845.USD","BK1589","IE0008369823.USD","IE00B543WZ88.USD","BK1521","LU0359202008.SGD","BK4581","BK4588","LU0326950275.SGD","SG9999004220.SGD","BK1161","IE00B5MMRT66.SGD","01093","LU0880133367.SGD","01276","LU1960683339.HKD","LU2543165471.USD","159760","BK1583","LABU","BK4585","IE0008368742.USD","LU1152091754.HKD","LU0314109678.HKD","LU1008478684.HKD","LU1226287875.USD","XLV","LU1807302812.USD"],"gpt_icon":0},{"id":"1184029467","title":"Hengrui Pharma Allocates 15.63 Million Yuan for Share Buyback on February 26","url":"https://stock-news.laohu8.com/highlight/detail?id=1184029467","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1184029467?lang=en_us&edition=fundamental","pubTime":"2026-02-26 16:27","pubTimestamp":1772094459,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (01276) announced that on February 26, the company repurchased 276,000 A-shares with a total investment of 15.6303 million yuan.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","LU1820825898.SGD","LU1997244956.HKD","LU2495084118.USD","LU1580142542.USD","LU1655091616.SGD","LU1023057109.AUD","LU2097828474.EUR","LU0359201612.USD","LU1255011170.USD","600276","BK0028","BK0239","BK0196","LU0359201885.HKD","LU1064131003.USD","BK0012","LU2148510915.USD","LU2328871848.SGD","LU1781817850.SGD","LU2543165471.USD","LU0359202008.SGD","BK0060","LU1969619763.USD","01276","LU2097828714.EUR","159982","LU2097828557.USD","LU2580892789.USD","LU1997245094.SGD","LU1328615791.USD","LU2488822045.USD","LU0405327148.USD","LU2097828631.EUR","LU2289578879.USD","LU2580892862.HKD","LU1146622755.USD","399300","BK1191","LU2097828805.USD","LU1997245177.USD","LU0405327494.USD","BK0188","LU1064130708.USD"],"gpt_icon":0},{"id":"1182468958","title":"Jiangsu Hengrui (600276) Announces Share Repurchase Results","url":"https://stock-news.laohu8.com/highlight/detail?id=1182468958","media":"Bulletin Express","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1182468958?lang=en_us&edition=fundamental","pubTime":"2026-02-26 16:20","pubTimestamp":1772094051,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276) submitted a Next Day Disclosure Return dated 26 February 2026. According to the announcement, the company repurchased 0.28 million A shares on 26...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"gpt_icon":0},{"id":"1188158344","title":"GTHT: Factor XI Drives New Era in Anticoagulant Therapy with Multi-Technological Approaches","url":"https://stock-news.laohu8.com/highlight/detail?id=1188158344","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188158344?lang=en_us&edition=fundamental","pubTime":"2026-02-25 13:58","pubTimestamp":1771999118,"startTime":"0","endTime":"0","summary":"Demographic aging and rising prevalence of cardiovascular diseases are driving continuous expansion in the antithrombotic drug market. Anticoagulants, as a core category, are experiencing steady...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0201","BK0028","LU0359201612.USD","BK1564","LU0359202008.SGD","06938","BK0184","LU2543165471.USD","BK0276","01276","02611","BK0188","BK0183","BK1147","LU1023057109.AUD","LU0359201885.HKD","BK0012","BK1161","BK1191","601211"],"gpt_icon":0},{"id":"2614772906","title":"China's Drug Regulator Puts Hengrui Pharmaceuticals' SHR-1918 Injection in Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=2614772906","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614772906?lang=en_us&edition=fundamental","pubTime":"2026-02-25 13:38","pubTimestamp":1771997936,"startTime":"0","endTime":"0","summary":"China's National Medical Products Administration placed SHR-1918 injection in its priority review after accepting the application of Jiangsu Hengrui Pharmaceuticals' (SHA:600276, HKG:1276) unit, Beiji","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1023057109.AUD","LU2543165471.USD","LU0359201612.USD","01276","LU0359202008.SGD","LU0359201885.HKD","BK1191"],"gpt_icon":0},{"id":"1189255692","title":"Hengrui Pharma's Novel Drug SHR-1918 Injection Receives Marketing Application Acceptance and Priority Review Status","url":"https://stock-news.laohu8.com/highlight/detail?id=1189255692","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1189255692?lang=en_us&edition=fundamental","pubTime":"2026-02-24 16:53","pubTimestamp":1771923195,"startTime":"0","endTime":"0","summary":"Jiangsu Hengrui Pharmaceuticals Co., Ltd. (600276.SH) announced that its subsidiary, Beijing Shengdi Pharmaceutical Co., Ltd., recently received a Notice of Acceptance from the National Medical...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1820825898.SGD","LU2328871848.SGD","LU2097828631.EUR","LU1064130708.USD","BK0183","BK1161","LU0359201612.USD","LU2097828714.EUR","BK0060","LU1781817850.SGD","LU2580892789.USD","LU2097828557.USD","LU1328615791.USD","LU2488822045.USD","LU0359202008.SGD","LU1997245177.USD","LU1580142542.USD","LU1146622755.USD","LU2097828474.EUR","LU1997244956.HKD","LU2580892862.HKD","600276","LU1655091616.SGD","BK0239","LU1255011170.USD","BK0012","LU1997245094.SGD","06978","LU0405327148.USD","LU2097828805.USD","159992","BK1574","LU1023057109.AUD","BK0196","LU2148510915.USD","LU2543165471.USD","LU2495084118.USD","LU0359201885.HKD","BK1191","LU1969619763.USD","LU1064131003.USD","01276","LU0405327494.USD","BK0028","BK0188","LU2289578879.USD"],"gpt_icon":0},{"id":"1173801222","title":"Hengrui Pharma's Innovative Drug HRS-5346 for Elevated Lipoprotein(a) Levels Added to Breakthrough Therapy List","url":"https://stock-news.laohu8.com/highlight/detail?id=1173801222","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173801222?lang=en_us&edition=fundamental","pubTime":"2026-02-12 20:20","pubTimestamp":1770898851,"startTime":"0","endTime":"0","summary":"Hengrui Pharma's subsidiary, Shandong Shengdi Pharmaceutical Co., Ltd., has recently seen its drug candidate HRS-5346, intended for the treatment of elevated lipoprotein(a) levels, included in the...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0183","BK0196","LU1997245177.USD","LU2097828714.EUR","LU1820825898.SGD","BK0012","LU1255011170.USD","LU1328615791.USD","LU0359202008.SGD","LU0405327148.USD","LU2580892789.USD","BK0060","159992","LU2097828805.USD","BK1161","LU1064131003.USD","LU2488822045.USD","LU2097828474.EUR","LU0359201612.USD","LU1997245094.SGD","LU2097828631.EUR","06978","LU0359201885.HKD","LU1146622755.USD","LU1655091616.SGD","LU2097828557.USD","LU0405327494.USD","LU1997244956.HKD","LU1781817850.SGD","LU2289578879.USD","LU1580142542.USD","BK0188","LU2328871848.SGD","LU2543165471.USD","LU2580892862.HKD","LU2148510915.USD","BK0028","01276","BK0239","LU1023057109.AUD","LU1064130708.USD","LU2495084118.USD","600276","BK1574","LU1969619763.USD","BK1191"],"gpt_icon":0},{"id":"1181439097","title":"Small Nucleic Acids Reshape Weight Loss Paradigm with INHBE and ALK7 Targets Showing Initial Validation","url":"https://stock-news.laohu8.com/highlight/detail?id=1181439097","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181439097?lang=en_us&edition=fundamental","pubTime":"2026-02-12 14:52","pubTimestamp":1770879137,"startTime":"0","endTime":"0","summary":"According to a research report, small nucleic acid drugs and GLP-1 based therapies demonstrate synergistic effects, with major weight loss companies already deploying small nucleic acid drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQDM52.EUR","IE00BZ08YS42.EUR","LU0359202008.SGD","BK1589","LU1023057109.AUD","SG9999004220.SGD","LU0359201885.HKD","BK1515","01276","00867","BK1593","161027","HK0000165453.HKD","IE00BZ08YR35.GBP","SG9999015978.USD","SG9999015952.SGD","SG9999015945.SGD","BK1521","IE00BZ08YT58.USD","SG9999015986.USD","BK1564","01177","601456","BK1191","BK0276","IE00BVYPNQ40.USD","LU0359201612.USD","BK1147","IE00BVYPNP33.GBP","IE00BMCWC346.EUR","01456","IE00BYV24P56.USD","LU2543165471.USD","LU2488822045.USD"],"gpt_icon":0},{"id":"2610600310","title":"Jiangsu Hengrui Medicine Gets Priority Review Approval for Colorectal Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2610600310","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610600310?lang=en_us&edition=fundamental","pubTime":"2026-02-11 13:37","pubTimestamp":1770788272,"startTime":"0","endTime":"0","summary":"China's drug regulator granted priority review approval to Jiangsu Hengrui Medicine  subsidiary Suzhou Shengdiya Biopharmaceutical's trastuzumab injectable, according to a Wednesday filing with the Shanghai bourse.The drug is indicated for Human Epidermal Growth Factor Receptor 2-positive colorectal cancer patients who have not obtained relief from previous treatments.China previously approved the drug for the non-small cell lung cancer indication.Shares rose 1% in Hong Kong during Wednesday afternoon trading.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1969619763.USD","LU2148510915.USD","LU2289578879.USD","LU2097828474.EUR","LU2097828631.EUR","LU1820825898.SGD","BK0188","LU2097828805.USD","LU1328615791.USD","LU2097828557.USD","LU2495084118.USD","01276","BK0028","BK0196","BK0239","LU2543165471.USD","BK0060","LU2580892789.USD","LU0405327494.USD","LU1781817850.SGD","LU2097828714.EUR","LU2488822045.USD","LU0359201612.USD","LU0359201885.HKD","600276","LU1064131003.USD","LU2328871848.SGD","LU1655091616.SGD","LU1997244956.HKD","BK0012","LU0359202008.SGD","LU1580142542.USD","BK1191","LU1023057109.AUD","LU1146622755.USD","LU2580892862.HKD","LU1997245094.SGD","LU0405327148.USD","LU1064130708.USD","LU1255011170.USD","BK0183","LU1997245177.USD"],"gpt_icon":0},{"id":"1158526329","title":"HENGRUI PHARMA's New Antibody Drug Application for Injectable SHR-A1811 Accepted and Granted Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1158526329","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158526329?lang=en_us&edition=fundamental","pubTime":"2026-02-10 20:40","pubTimestamp":1770727222,"startTime":"0","endTime":"0","summary":"HENGRUI PHARMA announced that its subsidiary, Shengdiya Biopharmaceutical, has received a notice of acceptance from the National Medical Products Administration for the marketing authorization...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0196","LU1064130708.USD","LU2097828805.USD","LU1064131003.USD","BK0188","LU0359201612.USD","LU1146622755.USD","LU2543165471.USD","LU1997245177.USD","600276","LU1023057109.AUD","BK0183","LU2488822045.USD","LU2097828557.USD","LU0405327148.USD","LU2148510915.USD","LU2495084118.USD","LU2097828714.EUR","LU0405327494.USD","LU2097828474.EUR","LU2580892789.USD","LU0359201885.HKD","LU2289578879.USD","LU2097828631.EUR","LU1969619763.USD","BK1191","LU1655091616.SGD","LU1820825898.SGD","BK0060","BK0028","BK0239","LU1781817850.SGD","LU1328615791.USD","LU1997244956.HKD","LU2580892862.HKD","LU1255011170.USD","LU1997245094.SGD","BK0012","LU1580142542.USD","LU0359202008.SGD","01276","LU2328871848.SGD"],"gpt_icon":0},{"id":"1188671385","title":"Hengrui Pharma's HRS-4642 Injection Granted Breakthrough Therapy Designation","url":"https://stock-news.laohu8.com/highlight/detail?id=1188671385","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188671385?lang=en_us&edition=fundamental","pubTime":"2026-02-06 17:56","pubTimestamp":1770371779,"startTime":"0","endTime":"0","summary":"Hengrui Pharma (600276.SH) announced that its HRS-4642 injection has been included in the Breakthrough Therapy Designation list by the Center for Drug Evaluation of the National Medical Products...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK0239","LU1023057109.AUD","LU1997245094.SGD","LU2097828714.EUR","LU1580142542.USD","LU2488822045.USD","LU2580892789.USD","LU1064130708.USD","BK0196","BK0183","LU2543165471.USD","01276","LU0359202008.SGD","LU0359201885.HKD","LU2097828805.USD","LU2495084118.USD","LU1064131003.USD","LU1328615791.USD","LU1655091616.SGD","LU1969619763.USD","600276","BK0060","LU2148510915.USD","LU1997245177.USD","BK0028","LU2580892862.HKD","LU1997244956.HKD","LU1255011170.USD","LU0405327148.USD","LU2097828474.EUR","LU0405327494.USD","BK0012","LU1820825898.SGD","LU0359201612.USD","LU2289578879.USD","LU1781817850.SGD","LU2097828557.USD","LU1146622755.USD","LU2097828631.EUR","LU2328871848.SGD","BK0188"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}